Home

February 2011

Circ: Congenital heart disease patients need 'uninterrupted' transitions of care (02/28/2011)

AIM: Older patients hesitant to take meds to prevent CV because of risks (02/28/2011)

CRT Video: Waksman discusses how healthcare reform impacts practice (02/28/2011)

CRT Q&A: Panel discusses optimizing door-to-balloon times in 2011 (02/28/2011)

NEJM: Shockable arrests occur more frequently in public locations (02/28/2011)

Resuscitation: CIRC trial hopes to clear confusion with AutoPulse CPR (02/28/2011)

Resuscitation: AEDs are safe in helicopters, with caveats (02/28/2011)

AEM: Most people unwilling to use automated external defibrillators (02/28/2011)

Lancet: Resuscitation devices improve on post-cardiac arrest standards (02/28/2011)

CMS to reimburse for pacemaker MR trials (02/26/2011)

HealthGrades names 50 Best Hospitals in U.S. (02/25/2011)

It is not wise to neglect the present for the future? (02/24/2011)

Medtronics CV line bolsters Q3, still moves to divest Physio-Control (02/24/2011)

FDA and industry square off over approval process (02/24/2011)

AHJ: Oral drugs, DES best for diabetics undergoing PCI (02/23/2011)

STEMI Networks: Not Why, But How (02/23/2011)

First Word: March Madness (02/23/2011)

Cardiac CT: Looking Beyond the Coronaries (02/23/2011)

Building Your Referral Base with High & Low Tech (02/23/2011)

The Tao of Medicine (02/23/2011)

Overcoming Hurdles for Effective Heart Failure Telemonitoring (02/23/2011)

JCE: Abnormal heart rate turbulence may predict heart disease (02/23/2011)

AIM: Treating CHD with aspirin is cheaper, more effective than no treatment (02/23/2011)

HIMSS: Strategies for getting CDS right (02/22/2011)

Study: Value of therapeutic hypothermia after cardiac arrest confirmed (02/21/2011)

HIMSS: Panel discerns how to measure quality for EHR adoption, usage (02/21/2011)

Louisiana AG sues GSK over Avandia (02/20/2011)

Circulation: TAVI mortality predictors vary at 30 days and one year (02/20/2011)

Medicines Co. skips into black in Q4 & FY10, bolstered by Angiomax sales (02/20/2011)

Spectranetics FY10 net loss remains flat, but upward swing in Q4 (02/20/2011)

ACR trial to question necessity of SPECT in CAD treatment planning (02/18/2011)

AHJ: Bivalirudin alone associated with lower risk of acquired thrombocytopenia (02/17/2011)

Mass. hits Novo Nordisk with subpoena over diabetes drugs (02/17/2011)

The ACC Corner | Lessons from the Field: A Woman in Cardiology (02/17/2011)

AIM: Benefits of inpatient intensive insulin therapy are unclear (02/16/2011)

2012 federal budget extends 'doc fix' for 2 years (02/16/2011)

JAMA: Black, elderly patients see higher readmissions, overhaul needed (02/15/2011)

JAMA: Docs should consider switching patients off Avandia (02/15/2011)

Atlanta startup receives grant for transapical access, closure system (02/15/2011)

Medicines nets up to $222M in Angiomax settlement with law firm (02/14/2011)

AIM: Auto referrals + patient convos boost CV rehab rates 45% (02/12/2011)

JACC: Female PAD patients lose mobility, function faster than men (02/11/2011)

FDA clears Rcadias coronary artery assessment system (02/11/2011)

ISC: Less than one-third of stroke patients receive timely thrombolysis (02/09/2011)

ISC: Ischemic strokes rise among teens & children, fall among middle-aged (02/09/2011)

Physio-Control, BeneChill to co-market portable hypothermia system (02/09/2011)

Feature: Small post-CABG infarcts have long-term prognostic significance (02/09/2011)

GSK updates Avandia labeling, based on FDA recommendations (02/09/2011)

Court maintains Medtronic owes Edwards $74M over CoreValve patent (02/09/2011)

JACC: Are the JUPITER recommendations for statin use really cost effective? (02/09/2011)

ISC: Apixaban effective in reducing stroke/embolism in afib patients (02/08/2011)

ISC: Stroke patients increasingly not taking meds, despite Part D coverage (02/08/2011)

Feature: Change sought in European device approval process (02/08/2011)

Merck's Q4, FY10 net income drops, partly due vorapaxar charges (02/08/2011)

Edwards posts mixed FY10, strong Q4 (02/05/2011)

Impella sales drive down Abiomeds Q3 losses, guidance raised (02/04/2011)

BMJ: P4P doesn't yield better hypertension outcomes (02/03/2011)

AIM: Hospitals that spend more have fewer inpatient deaths (02/02/2011)

Declining Lipitor sales hurt Pfizers FY10 net income (02/02/2011)

EHJ: Diabetics, CAD patients respond better to prasugrel than clopidogrel (02/02/2011)

Arena to slash 25% of workforce, will continue fight for lorcaserin (02/02/2011)

Lilly books double-digit income gains in FY10, Q4 (02/02/2011)

Circ: PPIs don't increase CV events, death for patients on Plavix (02/02/2011)

EU and U.S. device recall rates equal (02/02/2011)

Meta-analysis suggests statins not effective for low-risk patients (02/01/2011)

Lancet: Statins are effective, regardless of CRP levels (02/01/2011)

First Word: The Clinical Promise of IT (02/01/2011)

Cath Lab Oversight: Is Peer Review Enough? (02/01/2011)

STEMI & Heart Failure: How the EMR Tracks & Improves Care (02/01/2011)

Design by Adaptive Theme